1 results match your criteria: "University of California (K.P.[Affiliation]"
Suprachoroidal Triamcinolone Acetonide for Noninfectious Uveitis: Real-World Impact on Clinical Outcomes.
Am J Ophthalmol
December 2024
From the Department of Ophthalmology & Vision Science, University of California (K.P., A.H., P.E.-N., G.Y., K.M.), Davis, Sacramento, California, USA. Electronic address:
Article Synopsis
- The study aimed to assess the effects of suprachoroidal triamcinolone acetonide (TA) injections on patients with noninfectious uveitis, focusing on key outcomes like central subfield thickness (CST) and visual acuity.
- Data was collected from 61 eyes of 51 patients over two years, revealing a significant reduction in CST from 437.61 microns to 348.17 microns within 6 weeks following treatment, along with an improvement in fluorescein angiography scores.
- Results showed that while some patients needed additional treatment for macular edema over time, 41.2% of those followed for 24 weeks did not require further interventions, and